Literature DB >> 10849476

The bronchial microcirculation in asthma.

J Wilson1.   

Abstract

Airway wall remodelling in asthma involves a number of changes including increased vascularity, vasodilation and microvascular leakage. Evidence suggests that the number and size of bronchial vessels is increased in patients with asthma compared with normal controls. In particular, there may be increased numbers of vessels in patients with fatal asthma. Treatment with inhaled corticosteroids is now known to reduce this vascularity. Bronchial vessels may undergo proliferation in response to inflammatory stimuli. Many factors can induce angiogenesis including a range of mediators and growth factors. Others can cause a vascular response by causing vasodilation and microvascular leakage. Airway wall oedema is likely to be important in asthma but has not yet been quantified. It is thought that mast cells play a key role in modulating these vascular remodelling changes by releasing cytokines and growth factors. Many key issues remain to be resolved before we fully understand the role of the bronchial microcirculation in asthma. In the future, novel therapies may be directed towards angiogenesis, vasodilation and microvascular leakage.

Entities:  

Mesh:

Year:  2000        PMID: 10849476     DOI: 10.1046/j.1365-2222.2000.00098.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  15 in total

1.  Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.

Authors:  So Ri Kim; Kyung Sun Lee; Seoung Ju Park; Myung Shin Jeon; Yong Chul Lee
Journal:  J Clin Immunol       Date:  2012-02-24       Impact factor: 8.317

2.  Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

Authors:  Peter Baluk; Tuomas Tammela; Erin Ator; Natalya Lyubynska; Marc G Achen; Daniel J Hicklin; Michael Jeltsch; Tatiana V Petrova; Bronislaw Pytowski; Steven A Stacker; Seppo Ylä-Herttuala; David G Jackson; Kari Alitalo; Donald M McDonald
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 3.  Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.

Authors:  T C Theoharides; D Kempuraj; M Tagen; M Vasiadi; C L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 4.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

5.  Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.

Authors:  Elisa Ghelfi; Chen-Wei Yu; Harun Elmasri; Matthew Terwelp; Chun G Lee; Vineet Bhandari; Suzy A Comhair; Serpil C Erzurum; Gökhan S Hotamisligil; Jack A Elias; Sule Cataltepe
Journal:  Am J Pathol       Date:  2013-02-04       Impact factor: 4.307

Review 6.  Brothers and sisters: molecular insights into arterial-venous heterogeneity.

Authors:  Julius Aitsebaomo; Andrea L Portbury; Jonathan C Schisler; Cam Patterson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

7.  Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma.

Authors:  Norbert F Voelkel; Sarah Spiegel
Journal:  Immunol Cell Biol       Date:  2009-06-23       Impact factor: 5.126

8.  Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity.

Authors:  Seyed Mohammadreza Bolandi; Zohreh Abdolmaleki; Mohammad-Ali Assarehzadegan
Journal:  Inflammopharmacology       Date:  2021-03-19       Impact factor: 4.473

Review 9.  Airway vascular remodeling in asthma.

Authors:  John W Wilson; Tom Kotsimbos
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

Review 10.  Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines.

Authors:  Kanami Orihara; Akio Matsuda
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.